✦ LIBER ✦

Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis

✍ Scribed by Paul M. Derderian; Hagop M. Kantarjian; Moshe Talpaz; Susan O'Brien; Ann Cork; Elihu Estey; Sherry Pierce; Michael Keating

Book ID: 115684371
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 652 KB
Volume: 94
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(93)90122-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diverse mechanisms of mTOR activation in

Diverse mechanisms of mTOR activation in chronic and blastic phase of chronic myelogenous leukemia

✍ Stoklosa, Tomasz; Glodkowska-Mrowka, Eliza; Hoser, Grazyna; Kielak, Magdalena; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 726 KB

Treatment of the blastic phase of chroni

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside

✍ Hagop M. Kantarjian; Ronald S. Walters; Michael J. Keating; Moshe Talpaz; Borje 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Sudden onset of the blastic phase of chr

Sudden onset of the blastic phase of chronic myelogenous leukemia : Patterns and implications

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Deborah Thomas; St 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract ## BACKGROUND Therapeutic options in Philadelphia chromosome‐positive chronic myelogenous leukemia (Ph‐positive CML) in chronic phase include allogeneic stem cell transplantation (SCT) and treatments other than allogeneic SCT. The choice of therapy often depends on the mortality risk o

Results of decitabine therapy in the acc

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia

✍ Kantarjian, H M; O’Brien, S M; Keating, M; Beran, M; Estey, E; Giralt, S; Kornbl 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 197 KB

Response to therapy is independently ass

Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phase

✍ Hagop M. Kantarjian; Jianqin Shan; Terry Smith; Moshe Talpaz; Peter Kozuch; Mary 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

HCVAD plus imatinib or dasatinib in lymp

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

✍ Strati, Paolo; Kantarjian, Hagop; Thomas, Deborah; O'Brien, Susan; Konoplev, Ser 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB